OBJECTIVE: Psychosocial treatment seems to be effective in the management of schizophrenia, although less in the area of quality of life and social functioning. To study the effectiveness of a hallucination focused integrated treatment with cognitive-behaviour therapy and coping training among schizophrenia patients suffering from 'hearing voices'. METHOD: In a randomized controlled trial (RCT) with 31 patients in the integrated treatment condition and 32 patients in the routine care condition, quality of life was assessed with the self-report questionnaire of the WHO (Bref), and social role functioning with an interviewer based schedule, at entry and 9 (post-treatment) and 18 months later. RESULTS: Follow-up data suggest a significant improvement of quality of life and in particular in social role functioning (effect size 0.64) in favour of the integrated treatment. CONCLUSION: The integrated treatment seems to be effective in reducing overall disability levels and number of patients with serious disabilities.
RCT Entities:
OBJECTIVE: Psychosocial treatment seems to be effective in the management of schizophrenia, although less in the area of quality of life and social functioning. To study the effectiveness of a hallucination focused integrated treatment with cognitive-behaviour therapy and coping training among schizophreniapatients suffering from 'hearing voices'. METHOD: In a randomized controlled trial (RCT) with 31 patients in the integrated treatment condition and 32 patients in the routine care condition, quality of life was assessed with the self-report questionnaire of the WHO (Bref), and social role functioning with an interviewer based schedule, at entry and 9 (post-treatment) and 18 months later. RESULTS: Follow-up data suggest a significant improvement of quality of life and in particular in social role functioning (effect size 0.64) in favour of the integrated treatment. CONCLUSION: The integrated treatment seems to be effective in reducing overall disability levels and number of patients with serious disabilities.
Authors: A D Stant; S Castelein; R Bruggeman; J T van Busschbach; M van der Gaag; H Knegtering; D Wiersma Journal: Community Ment Health J Date: 2009-03-24
Authors: Muhammad Qutayba Almerie; Muhammad Okba Al Marhi; Muhammad Jawoosh; Mohamad Alsabbagh; Hosam E Matar; Nicola Maayan; Hanna Bergman Journal: Cochrane Database Syst Rev Date: 2015-06-09
Authors: Neil Thomas; Mark Hayward; Emmanuelle Peters; Mark van der Gaag; Richard P Bentall; Jack Jenner; Clara Strauss; Iris E Sommer; Louise C Johns; Filippo Varese; José Manuel García-Montes; Flavie Waters; Guy Dodgson; Simon McCarthy-Jones Journal: Schizophr Bull Date: 2014-07 Impact factor: 9.306